American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The predictive value of cell-of-origin subtype by Hans algorithm in 718 patients with large B cell lymphoma receiving polatuzumab vedotin
    Meeting Abstract

    Scheffer Cliff, E. R.; Pelaez, G. D.; Wan, F.; Iyengar, V.; Zhou, J.; Chung, K.; Abdel-Razeq, N.; Major, A.; Allen, J. M.; Sharp, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CDI9-CD28 (RO7443904) combination with glofitamab enhances T-cell proliferation and effector function in patients with relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
    Meeting Abstract

    Korfi, K.; Wilson, S.; Jiang, Z.; Christiansen, A.; Krishnan, S.; Jamois, C.; Blank, A.; Epp, A.; Silva, A.; Knuckles, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Cross-talk between leukemic blasts and T cells drives targetable T cell dysfunction in the AML tumor microenvironment
    Meeting Abstract

    DeWolf, S.; Ceglia, N.; Zatzman, M.; Gipson, B.; Elhanati, Y.; Katsamakis, Z.; Lees, H.; Weis, K.; Yepes, G.; Oliveira, B.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • RBMX regulates YTHDC1 nuclear condensates to promote nascent transcription in acute myeloid leukemia
    Meeting Abstract

    Wakiro, I.; Huang, Y.; Yang, X.; Xie, X.; Luo, H.; Chang, K.; Pierson, A.; Batchelor, E.; Cheng, Y.; Nguyen, D. T. T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final analysis of the safety and efficacy of venetoclax in combination with Pola-R-CHP for untreated high-risk BCL-2-positive B-cell lymphoma including double/triple hit lymphoma
    Meeting Abstract

    Diefenbach, C. S.; Zelenetz, A. D.; Herbaux, C.; Tani, M.; Houot, R.; Bastos-Oreiro, M.; Tilly, H.; Gastinne, T.; Thieblemont, C.; Leung, W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Fixed-duration epcoritamab + R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features: Long-term results from the EPCORE NHL-2 trial
    Meeting Abstract

    Falchi, L.; Offner, F.; de Vos, S.; Brody, J.; Cordoba, R.; Linton, K.; Snauwaert, S.; Clausen, M. R.; Oki, T.; Steele, A. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Predictors of early safety outcomes with axicabtagene ciloleucel (axi-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL)
    Meeting Abstract

    Strouse, C.; Farooq, U.; Shouval, R.; Vallurupalli, A.; Moskop, A.; Jacobson, C. A.; Locke, F.; Baird, J. H.; Strati, P.; Patel, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improving outcomes in plasmablastic lymphoma: A multicenter experience from an American cohort
    Meeting Abstract

    Hamby, M.; Egleston, B.; Frosch, Z. A. K.; Steiner, R. E.; Noy, A.; Carvajal, V.; Tolu, S. S.; Jean-Louis, G.; Amengual, J. E.; Patel, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prognostication and treatment-related outcomes in secondary central nervous system involvement of large B-cell lymphoma (SCNSL): Evidence from a large international cohort
    Meeting Abstract

    Alderuccio, J. P.; Khwaja, J.; Han, S.; Ghione, P.; Nizamuddin, I. A.; Saha, A.; Dong, N.; Wang, Y.; Cherng, H. J. J.; Tolu, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save